417 related articles for article (PubMed ID: 32024292)
1. Engineering Biology to Construct Microbial Chassis for the Production of Difficult-to-Express Proteins.
Kim K; Choe D; Lee DH; Cho BK
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024292
[TBL] [Abstract][Full Text] [Related]
2. Chasing bacterial chassis for metabolic engineering: a perspective review from classical to non-traditional microorganisms.
Calero P; Nikel PI
Microb Biotechnol; 2019 Jan; 12(1):98-124. PubMed ID: 29926529
[TBL] [Abstract][Full Text] [Related]
3. Retrosynthetic design of heterologous pathways.
Carbonell P; Planson AG; Faulon JL
Methods Mol Biol; 2013; 985():149-73. PubMed ID: 23417804
[TBL] [Abstract][Full Text] [Related]
4. Streamlining genomes: toward the generation of simplified and stabilized microbial systems.
Leprince A; van Passel MW; dos Santos VA
Curr Opin Biotechnol; 2012 Oct; 23(5):651-8. PubMed ID: 22651991
[TBL] [Abstract][Full Text] [Related]
5. Prototyping of microbial chassis for the biomanufacturing of high-value chemical targets.
Robinson CJ; Tellechea-Luzardo J; Carbonell P; Jervis AJ; Yan C; Hollywood KA; Dunstan MS; Currin A; Takano E; Scrutton NS
Biochem Soc Trans; 2021 Jun; 49(3):1055-1063. PubMed ID: 34100907
[TBL] [Abstract][Full Text] [Related]
6. Microbial cell factories based on filamentous bacteria, yeasts, and fungi.
Ding Q; Ye C
Microb Cell Fact; 2023 Jan; 22(1):20. PubMed ID: 36717860
[TBL] [Abstract][Full Text] [Related]
7. The new strategies to overcome challenges in protein production in bacteria.
Lipońska A; Ousalem F; Aalberts DP; Hunt JF; Boël G
Microb Biotechnol; 2019 Jan; 12(1):44-47. PubMed ID: 30484965
[TBL] [Abstract][Full Text] [Related]
8. Whole synthetic pathway engineering of recombinant protein production.
Brown AJ; Gibson SJ; Hatton D; Arnall CL; James DC
Biotechnol Bioeng; 2019 Feb; 116(2):375-387. PubMed ID: 30345502
[TBL] [Abstract][Full Text] [Related]
9. Chassis engineering for microbial production of chemicals: from natural microbes to synthetic organisms.
Liu J; Wu X; Yao M; Xiao W; Zha J
Curr Opin Biotechnol; 2020 Dec; 66():105-112. PubMed ID: 32738762
[TBL] [Abstract][Full Text] [Related]
10. Road to the future of systems biotechnology: CRISPR-Cas-mediated metabolic engineering for recombinant protein production.
Roointan A; Morowvat MH
Biotechnol Genet Eng Rev; 2016; 32(1-2):74-91. PubMed ID: 28052722
[TBL] [Abstract][Full Text] [Related]
11. From the first drop to the first truckload: commercialization of microbial processes for renewable chemicals.
Van Dien S
Curr Opin Biotechnol; 2013 Dec; 24(6):1061-8. PubMed ID: 23537815
[TBL] [Abstract][Full Text] [Related]
12. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
[TBL] [Abstract][Full Text] [Related]
13. Systems Metabolic Engineering Strategies: Integrating Systems and Synthetic Biology with Metabolic Engineering.
Choi KR; Jang WD; Yang D; Cho JS; Park D; Lee SY
Trends Biotechnol; 2019 Aug; 37(8):817-837. PubMed ID: 30737009
[TBL] [Abstract][Full Text] [Related]
14. The plastid genome as a chassis for synthetic biology-enabled metabolic engineering: players in gene expression.
Schindel HS; Piatek AA; Stewart CN; Lenaghan SC
Plant Cell Rep; 2018 Oct; 37(10):1419-1429. PubMed ID: 30039465
[TBL] [Abstract][Full Text] [Related]
15.
Hwang S; Lee Y; Kim JH; Kim G; Kim H; Kim W; Cho S; Palsson BO; Cho BK
Front Bioeng Biotechnol; 2021; 9():804295. PubMed ID: 34993191
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A.
Unzueta U; Vázquez F; Accardi G; Mendoza R; Toledo-Rubio V; Giuliani M; Sannino F; Parrilli E; Abasolo I; Schwartz S; Tutino ML; Villaverde A; Corchero JL; Ferrer-Miralles N
Appl Microbiol Biotechnol; 2015 Jul; 99(14):5863-74. PubMed ID: 25616525
[TBL] [Abstract][Full Text] [Related]
17. Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria. Biotechnology Bioengineering, 1990.
Bentley WE; Mirjalili N; Andersen DC; Davis RH; Kompala DS
Biotechnol Bioeng; 2009 Apr; 102(5):1284-97; discussion 1283. PubMed ID: 19215036
[No Abstract] [Full Text] [Related]
18. Exploring the potential of Saccharomyces cerevisiae for biopharmaceutical protein production.
Wang G; Huang M; Nielsen J
Curr Opin Biotechnol; 2017 Dec; 48():77-84. PubMed ID: 28410475
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Engineering and Synthetic Biology.
Ramzi AB
Adv Exp Med Biol; 2018; 1102():81-95. PubMed ID: 30382570
[TBL] [Abstract][Full Text] [Related]
20. Bacterial genome reduction for optimal chassis of synthetic biology: a review.
Ma S; Su T; Lu X; Qi Q
Crit Rev Biotechnol; 2024 Jun; 44(4):660-673. PubMed ID: 37380345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
